Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPantheon Resources plc Regulatory News (PANR)

Share Price Information for Pantheon Resources plc (PANR)

Share Price is delayed by 15 minutes
Get Live Data
13.68    1.20 (9.62%)
Bid:
13.19
Ask:
13.45
Spread: 0.26 (1.971%)
Market Cap: £199.44m
PANR Live PriceLast checked at - London Stock Exchange

Intraday Pantheon Resources plc Share Chart

Director/PDMR Shareholding

6 Jan 2017 07:00

RNS Number : 4906T
Pantheon Resources PLC
05 January 2017
 

 

 

 

 

5 January 2017

 

Pantheon Resources plc

 

Shareholdings of directors and persons discharging managerial responsibility (PDMR) / Key Management Personnel (KMP)

 

The notifications below, made in accordance with the requirements of the EU Market Abuse Regulation, provide further detail:

 

 

1 

Details of PDMR/person closely associated with them ('PCA')

 

a)

 

Name 

Phillip Anthony Gobe

2

Reason for the notification

a)

 

Position/status

Senior Independent Non-Executive Director

b)

 

Initial notification /Amendment

Initial notification of purchase of shares

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

 

a)

 

Name

Pantheon Resources plc

b)

 

LEI

N/A

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted 

 

a)

 

Description of the financial instrument, type of instrument

Identification code

 

Ordinary shares of 1 pence each

GB00B125SX82

b)

 

Nature of the transaction

On market purchase of ordinary shares 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

89.00p*

37,500

89.01p*

12,500

 

d)

 

Aggregated information

- Aggregated volume

 - Price

 

 

50,000

89.01p*

e)

 

Date of the transaction

5 January 2017

f)

 

Place of the transaction 

XLON

*Based on GBP:USD exchange rate of 1:1.2296

 

Further information:

 

Pantheon Resources plc

+44 20 7484 5359

Jay Cheatham, CEO

 

Justin Hondris, Director, Finance and Corporate Development

 

 

 

Stifel Nicolaus Europe Limited (Nominated Adviser and broker)

+44 20 7710 7600

Callum Stewart

 

Ashton Clanfield

Nicholas Rhodes

 

 

 

FTI Consulting

+44 20 3727 1000

Ed Westropp

 

James Styles

 

 

 

For further information on Pantheon Resources plc, see the website at: www.pantheonresources.com

Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of, this announcement.

 

This announcement contains inside information as defined in Article 7 of the Market Abuse Regulation No. 596/2014 and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHLLFEALAIEIID
Date   Source Headline
30th Dec 20227:00 amRNSOperational update
30th Dec 20227:00 amRNSFinal Results for the Year Ended 30 June 2022
14th Dec 20225:00 pmRNSQuarterly Repayment of Unsecured Convertible Bonds
8th Dec 20227:00 amRNSReservoir modelling report from Schlumberger
18th Nov 20221:22 pmRNSBlock Listing Six Monthly Return
10th Nov 20227:00 amRNSAcquisition of Key Leases & Operational Update
25th Oct 20227:00 amRNSOperational Update, Alkaid #2 Well
3rd Oct 20224:22 pmRNSTotal Voting Rights
26th Sep 20227:00 amRNSOperational Update, Alkaid #2 Well
20th Sep 20227:00 amRNSDirector/PDMR Notification
13th Sep 20221:21 pmRNSQuarterly Repayment of Unsecured Convertible Bonds
7th Sep 20222:30 pmRNSPantheon Graduates to the OTCQX Best Market
6th Sep 20227:00 amRNSOperational and Corporate Update
23rd Aug 20222:36 pmRNSReplacement Theta West #1 – Independent VAS Report
23rd Aug 20227:00 amRNSTheta West #1 Well – Independent Expert VAS Report
18th Aug 20227:00 amRNSOperational Update, Alkaid #2 Well
29th Jul 20227:00 amRNSOperational Update, Alkaid #2 Well
7th Jul 20227:00 amRNSSpudding of Alkaid #2 Well
28th Jun 20227:00 amRNSTR-1: Notification of major holdings
14th Jun 202210:34 amRNSQuarterly Repayment of Unsecured Convertible Bonds
31st May 20221:10 pmRNSTotal Voting Rights
18th May 20229:53 amRNSBlock Listing Application to AIM
16th May 20227:00 amRNSRig Contract Executed & Investor Presentation
4th May 20227:00 amRNSPartial Conversion of Unsecured Convertible Bonds
25th Apr 20227:00 amRNSResource Upgrade
20th Apr 20227:00 amRNSUpcoming Webinar – Registration Details
6th Apr 202210:01 amRNSConfirmation of Upcoming Webinar
5th Apr 20225:58 pmRNSTR-1: Notification of major holdings
31st Mar 20227:00 amRNSInterim Results for Six Months Ended 31/12/21
24th Mar 20227:00 amRNSTheta West #1 Testing Update
15th Mar 20227:00 amRNSIssue of Equity
9th Mar 20229:35 amRNSQuarterly Repayment of Unsecured Convertible Bonds
4th Mar 20222:14 pmRNSConversion of Shares
4th Mar 20227:00 amRNSOperations Update
21st Feb 20227:00 amRNSOperational Update
18th Feb 20227:00 amRNSPartial Conversion of Unsecured Convertible Bonds
15th Feb 20227:00 amRNSTheta West #1 Operational Update
7th Feb 20227:00 amRNSTalitha #A Testing Update
24th Jan 20224:53 pmRNSWebinar
24th Jan 202212:17 pmRNSResult of AGM
24th Jan 20227:00 amRNSSpudding of Theta West #1 Well & Operations Update
20th Jan 20227:00 amRNSExercise of Warrants
19th Jan 20227:02 amRNSAnnual Grant of Share Options to Directors & Staff
19th Jan 20227:00 amRNSDirector/PDMR Notification
13th Jan 20227:00 amRNSIssue of Equity & Exercise of Share Options
12th Jan 20229:10 amRNSTheta West Drilling Permit Approval & AGM Webinar
7th Jan 202212:05 pmRNSAnnual General Meeting & Covid Precautions
6th Jan 20227:00 amRNSOperations Update
4th Jan 20227:00 amRNSTR-1: Notification of major holdings
17th Dec 20219:23 amRNSTR-1: Notification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.